Valuation: ResMed, Inc.

Market Cap 34.13B 29.24B 27.4B 25.03B 47.24B 3,254B 47.71B 323B 126B 1,642B 128B 125B 5,436B P/E 2027 *
20.5x
P/E 2028 * 18.5x
Enterprise Value 33.18B 28.43B 26.64B 24.34B 45.93B 3,163B 46.38B 314B 122B 1,596B 125B 122B 5,285B EV / Sales 2027 *
5.7x
EV / Sales 2028 * 5.23x
Free-Float
37.57%
Yield 2027 *
1.12%
Yield 2028 * 1.24%
1 day+1.78%
1 week+7.55%
Current month+12.14%
1 month+21.16%
3 months+13.72%
6 months-6.31%
Current year-1.78%
1 week 228.38
Extreme 228.38
238.37
1 month 195.8
Extreme 195.795
238.37
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
285.08
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Chief Tech/Sci/R&D Officer - 01/02/2024
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
7/8/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
5/8/26 Sell

Founder

-8,000 0.0055%
7/7/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+1.78%+7.55%-17.22%+46.97% 34.13B
-0.09%+6.64%+28.00%+15.98% 232B
+0.40%+8.21%+3.97%-15.48% 152B
-0.46%-4.94%-20.62%+24.97% 131B
+1.73%-1.21%-52.56%-1.77% 72.26B
-0.92%-1.50%-16.64%-13.92% 51.57B
+0.41%-0.12%+12.38%+19.30% 52.38B
+0.87%+4.26%+29.90%+29.32% 43.71B
+0.90%+3.29%+38.63%+51.60% 40.72B
+0.79%+19.49%+125.76%+42.33% 33.97B
Average +0.44%+4.06%+13.16%+19.93% 84.42B
Weighted average by Cap. +0.27%+3.79%+8.24%+13.30%

Financials

2027 *2028 *
Net sales 5.82B 4.99B 4.67B 4.27B 8.05B 555B 8.13B 55.1B 21.45B 280B 21.85B 21.37B 927B 6.2B 5.31B 4.98B 4.55B 8.58B 591B 8.66B 58.71B 22.85B 298B 23.27B 22.77B 987B
Net income 1.63B 1.4B 1.31B 1.19B 2.25B 155B 2.28B 15.42B 6B 78.33B 6.11B 5.98B 259B 1.78B 1.53B 1.43B 1.31B 2.47B 170B 2.49B 16.88B 6.57B 85.72B 6.69B 6.55B 284B
Net Debt -947M -812M -761M -695M -1.31B -90.31B -1.32B -8.97B -3.49B -45.56B -3.56B -3.48B -151B -1.69B -1.45B -1.35B -1.24B -2.33B -161B -2.36B -15.97B -6.22B -81.11B -6.33B -6.19B -269B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
11,370
Date Price Change Volume
25/08/26 US$236.59 +1.78% 1,761,110
24/08/26 US$232.45 +0.40% 1,113,640
21/08/26 US$231.52 +1.35% 1,725,347
20/08/26 US$228.44 -0.96% 1,285,692
19/08/26 US$230.65 +4.85% 1,209,808
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
236.59USD
Average target price
245.50USD
Spread / Average Target
+3.77%

Quarterly revenue - Rate of surprise